Concepedia

Publication | Open Access

Assessment of potential predictive factors of dupilumab response in patients with moderate‐to‐severe atopic dermatitis

DOIFull Paper Access

11

Citations

27

References

2023

Year

Gemma Melé‐Ninot, Laia Curto‐Barredo, Montserrat Bonfill‐Ortí, V. Expósito‐Serrano, Mónica Munera‐Campos, Ignasi Figueras‐Nart, Constanza Riquelme‐Mc Loughlin, S. Gómez‐Armayones, Jorge Spertino, E. Serra‐Baldrich
Australasian Journal of Dermatology

Abstract

Dupilumab was an effective treatment in patients with moderate-to-severe AD. Additionally, sex and body mass index were significantly associated with achieving EASI-75 and an improvement of ≥2 points in the IGA scale, respectively, at week 52.

References

YearCitations

Page 1